What price for a year of life? A survey of U.S. and Canadian oncologists.

Abstract

6565 Background: New cancer drugs are increasingly expensive and raise difficult questions about the magnitude of therapeutic benefit needed to justify their incremental cost. In this context, it is unclear whether oncologists endorse standard thresholds of $50,000 to $100,000 per year of life. METHODS We surveyed 1,379 U.S. and 356 Canadian (Cdn… (More)

Topics

  • Presentations referencing similar topics